Relation of Supraventricular Arrhythmias Detected by Implantable Cardioverter Defibrillator and Air Pollutants

Introduction: One of the therapeutic approaches in cases with high-risk heart disease, particularly heart failure, is the implantation of an implantable cardioverter defibrillator (ICD) to avoid unexpected death. Supraventricular arrhythmias (SVAs) are one of the most common events in aforementioned...

Full description

Bibliographic Details
Published in:	Journal of Indian College of Cardiology
Main Authors:	Javad Shahabi, Amirhossein Azhari, Amin Rahimi-Pordanjani, Mohsen Safari
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2024-08-01
Subjects:	air pollution implantable cardioverter defibrillator supraventricular arrhythmias
Online Access:	https://journals.lww.com/10.4103/jicc.jicc_10_24

Similar Items

The effect of air pollution on ventricular arrhythmias in patients with implantable cardioverter defibrillator
by: Javad Shahabi, et al.
Published: (2023-01-01)

A case of supraventricular tachycardia misdiagnosis after dual‐chamber implantable cardioverter defibrillator implantation with His bundle pacing
by: Xianchao Sun, et al.
Published: (2023-05-01)

The association between statin dosage and malignant ventricular arrhythmias in patients with primary prevention implantable cardioverter-defibrillators for ischemic cardiomyopathy
by: Özge Çakmak Karaaslan, et al.
Published: (2023-01-01)

Subcutaneous Implantable Cardioverter-defibrillator in Preventing Ventricular Arrhythmia and Sudden Cardiac Death – A Single-center Experience
by: Amarapalli Jayachandra, et al.
Published: (2024-08-01)

Stepwise cardiac rehabilitation adjustment after exercise-induced implantable cardioverter defibrillator shock: a case report
by: Hidetoshi Yanagi, et al.
Published: (2025-04-01)

Dosimetric feasibility of stereotactic arrhythmia radioablation for ventricular tachycardia in patients with a subcutaneous implantable cardioverter defibrillator
by: Lena Kaestner, et al.
Published: (2025-07-01)

Prophylactic implantation of cardioverter‐defibrillator in patients with advanced light‐chain amyloidosis—A pilot study
by: Hui‐Qiang Wei, et al.
Published: (2025-04-01)

Implantable Cardioverter Defibrillator Tachycardia Therapies: Past, Present and Future Directions
by: Andrew M. Leong, et al.
Published: (2024-03-01)

Myocardial Scar Characterization and Future Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
by: Alwin B. P. Noordman, et al.
Published: (2021-08-01)

Risk of subsequent ventricular arrhythmia is higher in primary prevention patients with implantable cardioverter defibrillator than in secondary prevention patients
by: You Zhou, et al.
Published: (2019-10-01)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
by: Temirkhan Begisbayev, et al.
Published: (2022-05-01)

Intermuscular pocket for subcutaneous implantable cardioverter defibrillator: Single-center experience
by: Paola Ferrari, MD, et al.
Published: (2016-06-01)

Current status of wearable cardioverter‐defibrillator use in Japan
by: Reina Tonegawa‐Kuji, et al.
Published: (2024-08-01)

Subcutaneous cardioverter-defibrillator, patient selection, implantation, postoperative management in the Krasnoyarsk
by: A. V. Prokopenko, et al.
Published: (2022-09-01)

Incidence, Predictors, and Outcomes of Implantable Cardioverter‐Defibrillator Discharge Among People Living With HIV
by: Raza M. Alvi, et al.
Published: (2018-09-01)

Underrepresentation of women in implantable cardioverter defibrillator trials
by: Janet K. Han, et al.
Published: (2022-02-01)

Multiple Implantable Cardioverter-Defibrillator Shocks in Ischemic Cardiomyopathy Compels Coronary Vascularization Reassessment
by: Guşetu Gabriel, et al.
Published: (2023-12-01)

Psychological Problems of Patients with Implantable Cardioverter Defibrillators in Baghdad City.
by: Bayda'a A. Kareem
Published: (2014-04-01)

An unusual cause of implantable cardioverter defibrillator malfunction: Twiddler syndrome
by: Ufuk Eryılmaz, et al.
Published: (2013-10-01)

DX single-lead implantable cardioverter-defibrillator system with a floating atrial dipole: when, to whom, and why?
by: A. V. Prokopenko, et al.
Published: (2023-06-01)

Usage of the wearable cardioverter-defibrillator during pregnancy
by: J.-Jacqueline Olic, et al.
Published: (2022-08-01)

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator
by: Mohammad Abumayyaleh, et al.
Published: (2025-04-01)

Long‐term safety and efficacy of subcutaneous implantable cardioverter‐defibrillator compared with transvenous implantable cardioverter‐defibrillator in propensity score‐matched patients from Japan
by: Yuki Konno, et al.
Published: (2025-04-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS ARE THE MAIN MODE FOR SUDDEN CARDIAC DEATH PREVENTION
by: L. A. Bokeria, et al.
Published: (2019-02-01)

Implantable cardioverter-defibrillator programming after first occurrence of ventricular tachycardia in the Multicenter Automatic Defibrillator Implantation Trial–Reduce Inappropriate Therapy (MADIT-RIT)Key Findings
by: Mehmet K. Aktas, MD, MBA, FHRS, et al.
Published: (2020-06-01)

Prognostic comparison between implantable cardioverter‐defibrillator and amiodarone in cancer patients
by: Hirota Kida, et al.
Published: (2025-06-01)

Implantable cardioverter defibrillators for primary prevention in cardiomyopathies
by: Vineetha Kanneganti, et al.
Published: (2024-03-01)

Outcomes of permanent pacemakers and implantable cardioverter-defibrillators in an adult congenital heart disease population
by: Jason Chami, et al.
Published: (2024-03-01)

Reassessment of practical usage and accumulation of real‐world data of wearable cardioverter defibrillator (WCD) in Japan—Design paper for J‐WCDR study
by: Shinichi Niwano, et al.
Published: (2021-02-01)

Use of the wearable cardioverter-defibrillator – the Swiss experience
by: Boldizsar Kovacs, et al.
Published: (2020-09-01)

Patient characteristics and in‐hospital complications of subcutaneous implantable cardioverter‐defibrillator for Brugada syndrome in Japan
by: Iwanari Kawamura, et al.
Published: (2019-12-01)

T-Wave Oversensing with Contemporary Implantable Cardioverter–Defibrillators
by: Marc Strik, et al.
Published: (2023-10-01)

Patients’ Knowledge about Safe Measures Post Implantable Cardioverter Defibrillator
by: Mohammed Kadhum Sadaq, et al.
Published: (2025-09-01)

Sudden Death Due to Thrombosis Associated with Implantable Cardioverter-Defibrillator Electrodes
by: Jose Maria Frutos Perez, et al.
Published: (2021-03-01)

A case of pioneering subcutaneous implantable cardioverter defibrillator intervention in Timothy syndrome
by: Zixi Zhang, et al.
Published: (2024-11-01)

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis
by: Verena Tscholl, et al.
Published: (2021-08-01)

Quality of Life and Psychological Factors in Patients with Implantable Cardioverter Defibrillator
by: Akiko Suyama-Chishaki, MD PhD, et al.
Published: (2007-01-01)

Sex Differences in Outcomes of Patients with an Implantable Cardioverter-Defibrillator for the Secondary Prevention of Sudden Cardiac Death
by: Alwin B. P. Noordman, et al.
Published: (2024-04-01)

Prognostic value of noninvasive programmed stimulation in primary prevention implantable cardioverter‐defibrillator recipients
by: Piotr Futyma, et al.
Published: (2024-06-01)